US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 26.900
  • +0.750+2.87%
Close Nov 7 16:00 ET
  • 26.900
  • 0.0000.00%
Post 16:20 ET
983.91MMarket Cap-15612P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
--336.14M
--193.24M
373.31%147.48M
--31.16M
-Cash and cash equivalents
--110.16M
--74.27M
125.20%70.17M
--31.16M
-Short-term investments
--225.98M
--118.98M
--77.31M
--0
Restricted cash
--105K
--105K
--85K
--0
Other current assets
--4.42M
--5.38M
2,935.78%3.31M
--109K
Total current assets
--340.67M
--198.73M
382.51%150.87M
--31.27M
Non current assets
Net PPE
--5.24M
--5.49M
1,094.03%4M
--335K
-Gross PPE
--5.73M
--5.77M
1,079.14%4.13M
--350K
-Accumulated depreciation
---485K
---279K
-746.67%-127K
---15K
Other non current assets
--189K
--2.07M
--551K
----
Total non current assets
--5.43M
--7.56M
1,258.51%4.55M
--335K
Total assets
--346.1M
--206.29M
391.80%155.42M
--31.6M
Liabilities
Current liabilities
Payables
--1.88M
--1.45M
72.55%2.5M
--1.45M
-accounts payable
--1.88M
--1.45M
72.55%2.5M
--1.45M
Current accrued expenses
--3.81M
--6.71M
1,410.80%3.22M
--213K
Current debt and capital lease obligation
--703K
--686K
--670K
----
-Current capital lease obligation
--703K
--686K
--670K
--0
Current liabilities
--8.1M
--9.89M
429.34%8.8M
--1.66M
Non current liabilities
Long term debt and capital lease obligation
--1.12M
--1.3M
--1.48M
--0
-Long term capital lease obligation
--1.12M
--1.3M
--1.48M
--0
Preferred securities outside stock equity
--0
--234.74M
326.92%170.78M
--40M
Total non current liabilities
--1.12M
--236.04M
330.61%172.25M
--40M
Total liabilities
--9.21M
--245.92M
334.55%181.06M
--41.67M
Shareholders'equity
Share capital
--36K
--4K
0.00%4K
--4K
-common stock
--36K
--4K
0.00%4K
--4K
Retained earnings
---86.23M
---68.11M
-326.57%-45.44M
---10.65M
Paid-in capital
--423.26M
--28.63M
3,278.16%19.8M
--586K
Gains losses not affecting retained earnings
---183K
---160K
--4K
--0
Total stockholders'equity
--336.89M
---39.63M
-154.76%-25.63M
---10.06M
Total equity
--336.89M
---39.63M
-154.76%-25.63M
---10.06M
Currency Unit
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments --336.14M--193.24M373.31%147.48M--31.16M
-Cash and cash equivalents --110.16M--74.27M125.20%70.17M--31.16M
-Short-term investments --225.98M--118.98M--77.31M--0
Restricted cash --105K--105K--85K--0
Other current assets --4.42M--5.38M2,935.78%3.31M--109K
Total current assets --340.67M--198.73M382.51%150.87M--31.27M
Non current assets
Net PPE --5.24M--5.49M1,094.03%4M--335K
-Gross PPE --5.73M--5.77M1,079.14%4.13M--350K
-Accumulated depreciation ---485K---279K-746.67%-127K---15K
Other non current assets --189K--2.07M--551K----
Total non current assets --5.43M--7.56M1,258.51%4.55M--335K
Total assets --346.1M--206.29M391.80%155.42M--31.6M
Liabilities
Current liabilities
Payables --1.88M--1.45M72.55%2.5M--1.45M
-accounts payable --1.88M--1.45M72.55%2.5M--1.45M
Current accrued expenses --3.81M--6.71M1,410.80%3.22M--213K
Current debt and capital lease obligation --703K--686K--670K----
-Current capital lease obligation --703K--686K--670K--0
Current liabilities --8.1M--9.89M429.34%8.8M--1.66M
Non current liabilities
Long term debt and capital lease obligation --1.12M--1.3M--1.48M--0
-Long term capital lease obligation --1.12M--1.3M--1.48M--0
Preferred securities outside stock equity --0--234.74M326.92%170.78M--40M
Total non current liabilities --1.12M--236.04M330.61%172.25M--40M
Total liabilities --9.21M--245.92M334.55%181.06M--41.67M
Shareholders'equity
Share capital --36K--4K0.00%4K--4K
-common stock --36K--4K0.00%4K--4K
Retained earnings ---86.23M---68.11M-326.57%-45.44M---10.65M
Paid-in capital --423.26M--28.63M3,278.16%19.8M--586K
Gains losses not affecting retained earnings ---183K---160K--4K--0
Total stockholders'equity --336.89M---39.63M-154.76%-25.63M---10.06M
Total equity --336.89M---39.63M-154.76%-25.63M---10.06M
Currency Unit USDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Recent IPOs
Recent IPOs
Intraday+1.59%
Top Gainers Yesterday
Top Gainers Yesterday
Intraday-1.65%